Oct 29, 2014 7:35am EDT Matinas BioPharma Receives Authorization From Health Canada to Initiate Human Clinical Study of Lead Product Candidate MAT9001
Oct 20, 2014 8:05am EDT Matinas BioPharma Submits Investigational New Drug Application for Lead Product Candidate MAT9001 for the Treatment of Severe Hypertriglyceridemia
Sep 30, 2014 7:35am EDT Matinas BioPharma to Present at the 13th Annual BIO Investor Forum on Wednesday, October 8, 2014
Sep 08, 2014 7:05am EDT Matinas BioPharma Holdings, Inc. Approved to Trade on OTCQB Venture Stage Marketplace
Jul 22, 2014 8:15am EDT Matinas BioPharma Holdings, Inc. Common Stock Commences Trading on OTCBB Under Ticker Symbol MTNB
Jan 16, 2014 10:19am EST Matinas BioPharma Announces Presentation at "TEN"; Noble Financial Capital Markets' Tenth Annual Equity Conference on Wednesday, January 22, 2014
